Barclays PLC 13D/13G Filings for Kezar Life Sciences, Inc. (KZR)

Barclays PLC 13D and 13G filings for Kezar Life Sciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-03-21
5:54 pm
Unchanged		 2024-09-30 13G Kezar Life Sciences, Inc.
KZR		 Barclays PLC 0
0.000%		 0
(Unchanged)		 Filing
2024-11-14
12:24 pm
Sale		 2024-09-30 13G Kezar Life Sciences, Inc.
KZR		 Barclays PLC 0
0.000%		 -382,878decrease
(Position Closed)		 Filing
2024-02-14
6:44 pm
Purchase		 2024-02-13 13G Kezar Life Sciences, Inc.
KZR		 Barclays PLC 382,878
5.270%		 382,878increase
(New Position)		 Filing